stem cell treatment
Scope
Date
~
-
Energy
OCI to build $265 mn solar cell plant in Texas, expects $80 mn tax credit
South Korean solar cell company OCI Holdings Co. said on Thursday it will build a solar cell manufacturing plant in Texas through its US subsidiary ...
Mar 20, 2025 (Gmt+09:00)
-
Batteries
SK On to supply 100 GWh of EV batteries to Nissan
SK On Co. has landed a deal to supply nearly 100 gigawatt hours (GWh) of electric vehicle batteries to Japanese carmaker Nissan Motor Co., which cou...
Mar 20, 2025 (Gmt+09:00)
-
Hydrogen economy
Hyundai Motor to build fuel cell plant in South Korea
Hyundai Motor Co. will build a local fuel cell plant in South Korea, accelerating its bid to create an entire hydrogen fuel cell value chain in line...
Mar 11, 2025 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins EU approval for autoimmune disease treatment Avtozma
Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...
Feb 25, 2025 (Gmt+09:00)
-
Energy
Korea’s OCI, Israel’s Arava Power to jointly build solar cell plant in Texas
OCI Energy Co., a US subsidiary of South Korea’s OCI Holdings Co., and Israel’s Arava Power will jointly build a solar cell power plant ...
Feb 25, 2025 (Gmt+09:00)
-
Corporate restructuring
SK Ecoplant seeks to sell waste treatment business for $1.4 billion
SK Ecoplant Co., a South Korean construction engineering and waste management company under SK Group, is seeking to dispose of its waste treatment b...
Feb 12, 2025 (Gmt+09:00)
-
Mergers & Acquisitions
LG Chem embarks on sale of dermal filler business worth $343 million
LG Chem Ltd., the world’s fourth-largest chemicals producer that is fostering vaccine and new drug development as new growth drivers, has kick...
Feb 09, 2025 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Vegzelma: Most-prescribed cancer treatment in Europe
South Korea’s leading biosimilar drug developer Celltrion Inc.'s Vegzelma, a cancer drug referencing global biopharma Roche’s Avastin, h...
Feb 05, 2025 (Gmt+09:00)
-
Energy
Hanwha Q Cells sells two solar power plant projects in US
Hanwha Q Cells Co., a solar panel manufacturing arm of South Korea's Hanwha Solutions Corp., said on Wednesday that it sold its two large-scale sola...
Jan 22, 2025 (Gmt+09:00)
-
Bio & Pharma
Yuhan’s lung cancer drug gets OK in Europe
Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...
Dec 31, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion obtains approval of Steqeyma from FDA
South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...
Dec 18, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Pharmteco bags obesity treatment deal worth up to $1.4 bn
SK Pharmteco Co., a contract development and manufacturing organization (CDMO), has secured an obesity treatment order worth up to 2 trillion won ($...
Dec 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets approval of Omlyclo in Canada
South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...
Dec 09, 2024 (Gmt+09:00)
-
Batteries
LG Energy set to acquire GM’s $1 bn stake in Ultium JV plant in Michigan
South Korea’s LG Energy Solution Ltd. plans to acquire General Motors Co.’s stake in their battery joint venture plant in Lansing, Michi...
Dec 03, 2024 (Gmt+09:00)
-
Energy
Hanwha Q cells’ US subsidiary EnFin raises $321 mn through ABS
Hanwha Q Cells Co., the solar power unit of South Korea’s chemicals-to-defense conglomerate Hanwha Group known as Qcells in overseas markets, ...
Nov 22, 2024 (Gmt+09:00)
-
Batteries
LG Energy to supply 2170-type cells to Bear Robotics
South Korea’s LG Energy Solution Ltd. said on Monday it has signed an initial agreement to supply cylindrical battery cells to Bear Robotics I...
Nov 18, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion releases Steqeyma in Europe
South Korea's Celltrion Inc. said on Monday it released Steqeyma (ustekinumab) in Europe, the biosimilar of autoimmune disease treatment Stelara.T...
Nov 05, 2024 (Gmt+09:00)
-
Energy
Hanwha Q Cells, OCI to benefit from expanded US CHIPS Act subsidies
South Korean solar cell companies such as Hanwha Q Cells Co. and OCI Holdings Co. are set to benefit from expanded subsidies covered by the US CHIPS...
Oct 31, 2024 (Gmt+09:00)
-
Energy
DS Dansuk wins $750 mn SAF material order from Phillips 66
South Korea's DS Dansuk Co., which operates bioenergy, battery, and plastic recycling businesses, said on Monday it signed a 1 trillion won ($750 mi...
Oct 29, 2024 (Gmt+09:00)
-
Bio & Pharma
ViGenCell obtains approval for HLA-B5801 genetic diagnostic kit for adverse reactions to gout treatment
ViGenCell, a company specializing in immunotherapy, announced on Friday that it has obtained approval from the Ministry of Food and Drug Safety (MFD...
Oct 25, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience's SKYCellflu approved in Indonesia
SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, said on Wednesday that The Indonesian Food and Drug Authority BPOM ...
Oct 24, 2024 (Gmt+09:00)
-
Batteries
LG Energy, Stellantis’ EV battery JV in Canada mass-produces modules
LG Energy Solution Ltd., the world’s third-largest electric vehicle battery manufacturer, said on Wednesday its joint venture in Canada with m...
Oct 23, 2024 (Gmt+09:00)
-
Batteries
LG Energy to supply batteries for Ford's electric commercial vehicles
LG Energy Solution Ltd., the world’s third-largest electric vehicle battery manufacturer, is set to supply battery cells and modules to US For...
Oct 15, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion's anti cancer drugs hold 90% market share in C.America
South Korea’s Celltrion Inc. said on Friday that its cancer treatments have captured a 90% market share in several Central American countries....
Oct 11, 2024 (Gmt+09:00)
-
Energy
Hanwha Q Cells sells 142 MW solar power plant in Washington
Hanwha Q Cells Co., a solar panel manufacturing arm of South Korea's Hanwha Solutions Corp., said on Wednesday that it sold a 142-megawatt solar pow...
Oct 02, 2024 (Gmt+09:00)
-
Bio & Pharma
Osstem Implant to boost digital dentistry business
South Korea's Osstem Implant Co., the world’s fourth-largest dental implant maker, will enhance its software system of digital dentistry. ...
Sep 24, 2024 (Gmt+09:00)
-
Shipping & Shipbuilding
Hanwha unveils carbon-free gas carrier amid tougher rules
Hanwha Ocean Co., South Korea’s third-largest shipbuilder, has introduced a carbon-free gas carrier to meet the growing demand for eco-friendl...
Sep 20, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to supply breast, stomach cancer treatment to Brazil
Celltrion Inc., South Korea’s largest biosimilar maker, announced on Friday that its breast and stomach cancer treatment "Herzuma" (active ing...
Sep 13, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Group’s 3rd-generation daughter comes to the fore
Chey Yoon-chung, the eldest daughter of SK Group Chairman Chey Tae-won, unexpectedly made her debut during an SK Biopharmaceuticals Co. video confer...
Aug 30, 2024 (Gmt+09:00)
-
Hydrogen economy
HD KSOE buys Finnish fuel cell maker Convion for $81 mn
HD Hydrogen, a unit of HD Korea Shipbuilding & Offshore Engineering Co. (HD KSOE), has acquired Convion Ltd, a Finnish hydrogen fuel cell maker,...
Aug 26, 2024 (Gmt+09:00)
Latest News
- 1 BMW Surpasses Mercedes in Sales – Imported Car Market 'Shake-Up'
- 2 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 3 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 4 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 5 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google